0001012975-19-000673.txt : 20191112 0001012975-19-000673.hdr.sgml : 20191112 20191112155059 ACCESSION NUMBER: 0001012975-19-000673 CONFORMED SUBMISSION TYPE: 13F-HR PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20190930 FILED AS OF DATE: 20191112 DATE AS OF CHANGE: 20191112 EFFECTIVENESS DATE: 20191112 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ARCH VENTURE CORP CENTRAL INDEX KEY: 0001274403 IRS NUMBER: 000000000 FILING VALUES: FORM TYPE: 13F-HR SEC ACT: 1934 Act SEC FILE NUMBER: 028-19358 FILM NUMBER: 191209071 BUSINESS ADDRESS: STREET 1: C/O ARCH VENTURE PARTNERS STREET 2: 8755 W. HIGGINS RD. #1025 CITY: CHICAGO STATE: IL ZIP: 60631 BUSINESS PHONE: 7733806600 MAIL ADDRESS: STREET 1: C/O ARCH VENTURE PARTNERS STREET 2: 8755 W. HIGGINS RD. #1025 CITY: CHICAGO STATE: IL ZIP: 60631 13F-HR 1 primary_doc.xml 13F-HR LIVE false false false 0001274403 XXXXXXXX 09-30-2019 09-30-2019 ARCH VENTURE CORP
C/O ARCH VENTURE PARTNERS 8755 W. HIGGINS RD. #1025 CHICAGO IL 60631
13F HOLDINGS REPORT 028-19358 N
Mark McDonnell Managing Director, CFO and CAO 773-380-6600 /s/ Mark McDonnell Chicago IL 11-12-2019 0 5 91368 false
INFORMATION TABLE 2 ARCH.xml CHIASMA INC COM 16706W102 5924 1196776 SH SOLE 0 0 1196776 FATE THERAPEUTICS INC COM 31189P102 11126 716392 SH SOLE 0 0 716392 KURA ONCOLOGY INC COM 50127T109 13749 906307 SH SOLE 0 0 906307 RUBIUS THERAPEUTICS INC COM 78116T103 20554 2618351 SH SOLE 0 0 2618351 SYROS PHARMACEUTICALS INC COM 87184Q107 40015 3855051 SH SOLE 0 0 3855051